Skip to content
The Policy VaultThe Policy Vault

Imkeldi (imatinib) — Highmark

Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML)

Initial criteria

  • member has a diagnosis of Ph+ CML (ICD-10: C92.1) AND meets criteria as specified in subsequent sections (criteria incomplete in this chunk)